BCAL Diagnostics Stock

BCAL Diagnostics EBIT per Share

The EBIT per Share of BCAL Diagnostics (BDX.AX) as of Aug 15, 2026 is -0.02 AUD. In the previous year, EBIT per Share was -0.03 AUD — a change of -21.66% (higher).

EBIT per Share

-0.02AUD

YoY

-21.66%

Last updated:

EBIT per Share of BCAL Diagnostics is 2026 -0.02 AUD. EBIT per Share of BCAL Diagnostics was 2025 -0.03 AUD. It decreases by -21.66% higher compared to the previous year.
Access this data via the Eulerpool API
Get Free API Key

BCAL Diagnostics Stock analysis

What does BCAL Diagnostics do? BCAL Diagnostics is one of the most popular companies on Eulerpool.

Frequently Asked Questions about BCAL Diagnostics stock

EBIT per Share of BCAL Diagnostics is -0.02 AUD in 2026.

EBIT per Share of BCAL Diagnostics changed from -0.03 AUD to -0.02 AUD, representing a -21.66% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBIT per Share BCAL Diagnostics since 2006 – with annual values, charts, and detailed analysis.

EBIT per Share measures operating profit allocated to each outstanding share.

Access this data via the Eulerpool API
Get Free API Key

Income Statement — BCAL Diagnostics

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — BCAL Diagnostics